Gamma Irradiation-Inactivated Respiratory Syncytial Virus Vaccine Provides Protection but Exacerbates Pulmonary Inflammation by Switching from Prefusion to Postfusion F Protein

ABSTRACT Respiratory syncytial virus (RSV) is a common respiratory pathogen that causes lower respiratory diseases among infants and elderly people. Moreover, formalin-inactivated RSV (FI-RSV) vaccine induces serious enhanced respiratory disease (ERD). Radiation has been investigated as an alternati...

Full description

Bibliographic Details
Main Authors: Fengjia Chen, Hae-Ran Park, Hyun Jung Ji, Yeongkag Kwon, Min-Kyu Kim, Joon Young Song, Ki Bum Ahn, Ho Seong Seo
Format: Article
Language:English
Published: American Society for Microbiology 2023-08-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.01358-23
_version_ 1797741743479717888
author Fengjia Chen
Hae-Ran Park
Hyun Jung Ji
Yeongkag Kwon
Min-Kyu Kim
Joon Young Song
Ki Bum Ahn
Ho Seong Seo
author_facet Fengjia Chen
Hae-Ran Park
Hyun Jung Ji
Yeongkag Kwon
Min-Kyu Kim
Joon Young Song
Ki Bum Ahn
Ho Seong Seo
author_sort Fengjia Chen
collection DOAJ
description ABSTRACT Respiratory syncytial virus (RSV) is a common respiratory pathogen that causes lower respiratory diseases among infants and elderly people. Moreover, formalin-inactivated RSV (FI-RSV) vaccine induces serious enhanced respiratory disease (ERD). Radiation has been investigated as an alternative approach for producing inactivated or live-attenuated vaccines, which enhance the antigenicity and heterogeneous protective effects of vaccines compared with conventional formalin inactivation. In this study, we developed an RSV vaccine using gamma irradiation and analyzed its efficacy against RSV vaccine-induced ERD in a mouse model. Although gamma irradiation-inactivated RSV (RI-RSV) carbonylation was lower than FI-RSV carbonylation and RI-RSV showed a significant antibody production and viral clearance, RI-RSV caused more obvious body weight loss, pulmonary eosinophil infiltration, and pulmonary mucus secretion. Further, the conversion of prefusion F (pre-F) to postfusion F (post-F) was significant for both RI-RSV and FI-RSV, while that of RI-RSV was significantly higher than that of FI-RSV. We found that the conversion from pre- to post-F during radiation was caused by radiation-induced reactive oxygen species. Although we could not propose an effective RSV vaccine manufacturing method, we found that ERD was induced by RSV vaccine by various biochemical effects that affect antigen modification during RSV vaccine manufacturing, rather than simply by the combination of formalin and alum. Therefore, these biochemical actions should be considered in future developments of RSV vaccine. IMPORTANCE Radiation inactivation for viral vaccine production has been known to elicit a better immune response than other inactivation methods due to less surface protein damage. However, we found in this study that radiation-inactivated RSV (RI-RSV) vaccine induced a level of immune response similar to that induced by formalin-inactivated RSV (FI-RSV). Although RI-RSV vaccine showed less carbonylation than FI-RSV, it induced more conformational changes from pre-F to post-F due to the gamma radiation-induced reactive oxygen species response, which may be a key factor in RI-RSV-induced ERD. Therefore, ERD induced by RSV vaccine may be due to pre-F to post-F denaturation by random protein modifications caused by external stress. Our findings provide new ideas for inactivated vaccines for RSV and other viruses and confirm the importance of pre-F in RSV vaccines.
first_indexed 2024-03-12T14:31:03Z
format Article
id doaj.art-223cf8179fa94e859bb74c2554ed7ca3
institution Directory Open Access Journal
issn 2165-0497
language English
last_indexed 2024-03-12T14:31:03Z
publishDate 2023-08-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj.art-223cf8179fa94e859bb74c2554ed7ca32023-08-17T13:04:14ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972023-08-0111410.1128/spectrum.01358-23Gamma Irradiation-Inactivated Respiratory Syncytial Virus Vaccine Provides Protection but Exacerbates Pulmonary Inflammation by Switching from Prefusion to Postfusion F ProteinFengjia Chen0Hae-Ran Park1Hyun Jung Ji2Yeongkag Kwon3Min-Kyu Kim4Joon Young Song5Ki Bum Ahn6Ho Seong Seo7Accelerator Radioisotope Research Section, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Republic of KoreaAccelerator Radioisotope Research Section, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Republic of KoreaAccelerator Radioisotope Research Section, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Republic of KoreaAccelerator Radioisotope Research Section, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Republic of KoreaAccelerator Radioisotope Research Section, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Republic of KoreaDepartment of Internal Medicine, Korea University College of Medicine, Seoul, Republic of KoreaAccelerator Radioisotope Research Section, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Republic of KoreaAccelerator Radioisotope Research Section, Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute, Jeongeup, Republic of KoreaABSTRACT Respiratory syncytial virus (RSV) is a common respiratory pathogen that causes lower respiratory diseases among infants and elderly people. Moreover, formalin-inactivated RSV (FI-RSV) vaccine induces serious enhanced respiratory disease (ERD). Radiation has been investigated as an alternative approach for producing inactivated or live-attenuated vaccines, which enhance the antigenicity and heterogeneous protective effects of vaccines compared with conventional formalin inactivation. In this study, we developed an RSV vaccine using gamma irradiation and analyzed its efficacy against RSV vaccine-induced ERD in a mouse model. Although gamma irradiation-inactivated RSV (RI-RSV) carbonylation was lower than FI-RSV carbonylation and RI-RSV showed a significant antibody production and viral clearance, RI-RSV caused more obvious body weight loss, pulmonary eosinophil infiltration, and pulmonary mucus secretion. Further, the conversion of prefusion F (pre-F) to postfusion F (post-F) was significant for both RI-RSV and FI-RSV, while that of RI-RSV was significantly higher than that of FI-RSV. We found that the conversion from pre- to post-F during radiation was caused by radiation-induced reactive oxygen species. Although we could not propose an effective RSV vaccine manufacturing method, we found that ERD was induced by RSV vaccine by various biochemical effects that affect antigen modification during RSV vaccine manufacturing, rather than simply by the combination of formalin and alum. Therefore, these biochemical actions should be considered in future developments of RSV vaccine. IMPORTANCE Radiation inactivation for viral vaccine production has been known to elicit a better immune response than other inactivation methods due to less surface protein damage. However, we found in this study that radiation-inactivated RSV (RI-RSV) vaccine induced a level of immune response similar to that induced by formalin-inactivated RSV (FI-RSV). Although RI-RSV vaccine showed less carbonylation than FI-RSV, it induced more conformational changes from pre-F to post-F due to the gamma radiation-induced reactive oxygen species response, which may be a key factor in RI-RSV-induced ERD. Therefore, ERD induced by RSV vaccine may be due to pre-F to post-F denaturation by random protein modifications caused by external stress. Our findings provide new ideas for inactivated vaccines for RSV and other viruses and confirm the importance of pre-F in RSV vaccines.https://journals.asm.org/doi/10.1128/spectrum.01358-23respiratory syncytial virusenhanced respiratory diseaseinactivated vaccinegamma irradiation inactivationprefusion Fpostfusion F
spellingShingle Fengjia Chen
Hae-Ran Park
Hyun Jung Ji
Yeongkag Kwon
Min-Kyu Kim
Joon Young Song
Ki Bum Ahn
Ho Seong Seo
Gamma Irradiation-Inactivated Respiratory Syncytial Virus Vaccine Provides Protection but Exacerbates Pulmonary Inflammation by Switching from Prefusion to Postfusion F Protein
Microbiology Spectrum
respiratory syncytial virus
enhanced respiratory disease
inactivated vaccine
gamma irradiation inactivation
prefusion F
postfusion F
title Gamma Irradiation-Inactivated Respiratory Syncytial Virus Vaccine Provides Protection but Exacerbates Pulmonary Inflammation by Switching from Prefusion to Postfusion F Protein
title_full Gamma Irradiation-Inactivated Respiratory Syncytial Virus Vaccine Provides Protection but Exacerbates Pulmonary Inflammation by Switching from Prefusion to Postfusion F Protein
title_fullStr Gamma Irradiation-Inactivated Respiratory Syncytial Virus Vaccine Provides Protection but Exacerbates Pulmonary Inflammation by Switching from Prefusion to Postfusion F Protein
title_full_unstemmed Gamma Irradiation-Inactivated Respiratory Syncytial Virus Vaccine Provides Protection but Exacerbates Pulmonary Inflammation by Switching from Prefusion to Postfusion F Protein
title_short Gamma Irradiation-Inactivated Respiratory Syncytial Virus Vaccine Provides Protection but Exacerbates Pulmonary Inflammation by Switching from Prefusion to Postfusion F Protein
title_sort gamma irradiation inactivated respiratory syncytial virus vaccine provides protection but exacerbates pulmonary inflammation by switching from prefusion to postfusion f protein
topic respiratory syncytial virus
enhanced respiratory disease
inactivated vaccine
gamma irradiation inactivation
prefusion F
postfusion F
url https://journals.asm.org/doi/10.1128/spectrum.01358-23
work_keys_str_mv AT fengjiachen gammairradiationinactivatedrespiratorysyncytialvirusvaccineprovidesprotectionbutexacerbatespulmonaryinflammationbyswitchingfromprefusiontopostfusionfprotein
AT haeranpark gammairradiationinactivatedrespiratorysyncytialvirusvaccineprovidesprotectionbutexacerbatespulmonaryinflammationbyswitchingfromprefusiontopostfusionfprotein
AT hyunjungji gammairradiationinactivatedrespiratorysyncytialvirusvaccineprovidesprotectionbutexacerbatespulmonaryinflammationbyswitchingfromprefusiontopostfusionfprotein
AT yeongkagkwon gammairradiationinactivatedrespiratorysyncytialvirusvaccineprovidesprotectionbutexacerbatespulmonaryinflammationbyswitchingfromprefusiontopostfusionfprotein
AT minkyukim gammairradiationinactivatedrespiratorysyncytialvirusvaccineprovidesprotectionbutexacerbatespulmonaryinflammationbyswitchingfromprefusiontopostfusionfprotein
AT joonyoungsong gammairradiationinactivatedrespiratorysyncytialvirusvaccineprovidesprotectionbutexacerbatespulmonaryinflammationbyswitchingfromprefusiontopostfusionfprotein
AT kibumahn gammairradiationinactivatedrespiratorysyncytialvirusvaccineprovidesprotectionbutexacerbatespulmonaryinflammationbyswitchingfromprefusiontopostfusionfprotein
AT hoseongseo gammairradiationinactivatedrespiratorysyncytialvirusvaccineprovidesprotectionbutexacerbatespulmonaryinflammationbyswitchingfromprefusiontopostfusionfprotein